211 related articles for article (PubMed ID: 11441025)
1. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis.
McMahon GA; Petitclerc E; Stefansson S; Smith E; Wong MK; Westrick RJ; Ginsburg D; Brooks PC; Lawrence DA
J Biol Chem; 2001 Sep; 276(36):33964-8. PubMed ID: 11441025
[TBL] [Abstract][Full Text] [Related]
2. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
[TBL] [Abstract][Full Text] [Related]
3. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
Wilson MJ; Sinha AA
Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling.
Stefansson S; McMahon GA; Petitclerc E; Lawrence DA
Curr Pharm Des; 2003; 9(19):1545-64. PubMed ID: 12871067
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 inhibits prostate tumor growth through endothelial apoptosis.
Chen SC; Henry DO; Reczek PR; Wong MK
Mol Cancer Ther; 2008 May; 7(5):1227-36. PubMed ID: 18483310
[TBL] [Abstract][Full Text] [Related]
6. Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.
Maillard C; Jost M; Rømer MU; Brunner N; Houard X; Lejeune A; Munaut C; Bajou K; Melen L; Dano K; Carmeliet P; Fusenig NE; Foidart JM; Noel A
Neoplasia; 2005 Jan; 7(1):57-66. PubMed ID: 15720817
[TBL] [Abstract][Full Text] [Related]
7. SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis.
Masuda T; Hattori N; Senoo T; Akita S; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Kohno N
Mol Cancer Ther; 2013 Nov; 12(11):2378-88. PubMed ID: 23990114
[TBL] [Abstract][Full Text] [Related]
8. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin.
Isogai C; Laug WE; Shimada H; Declerck PJ; Stins MF; Durden DL; Erdreich-Epstein A; DeClerck YA
Cancer Res; 2001 Jul; 61(14):5587-94. PubMed ID: 11454712
[TBL] [Abstract][Full Text] [Related]
10. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.
Devy L; Blacher S; Grignet-Debrus C; Bajou K; Masson V; Gerard RD; Gils A; Carmeliet G; Carmeliet P; Declerck PJ; Nöel A; Foidart JM
FASEB J; 2002 Feb; 16(2):147-54. PubMed ID: 11818362
[TBL] [Abstract][Full Text] [Related]
11. [Role of PAI-1 plasminogen activator inhibitor in tumor invasion and angiogenesis].
Bajou K
Bull Mem Acad R Med Belg; 2002; 157(5-6):313-8. PubMed ID: 12557575
[TBL] [Abstract][Full Text] [Related]
12. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model.
Kibbey MC; Grant DS; Kleinman HK
J Natl Cancer Inst; 1992 Nov; 84(21):1633-8. PubMed ID: 1279183
[TBL] [Abstract][Full Text] [Related]
13. Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth.
Bajou K; Maillard C; Jost M; Lijnen RH; Gils A; Declerck P; Carmeliet P; Foidart JM; Noel A
Oncogene; 2004 Sep; 23(41):6986-90. PubMed ID: 15286708
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis.
Inoue M; Sawada T; Uchima Y; Kimura K; Nishihara T; Tanaka H; Yashiro M; Yamada N; Ohira M; Hirakawa K
Oncol Rep; 2005 Dec; 14(6):1445-51. PubMed ID: 16273237
[TBL] [Abstract][Full Text] [Related]
15. Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries.
Peng L; Bhatia N; Parker AC; Zhu Y; Fay WP
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):934-9. PubMed ID: 12067901
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model.
de Waard V; Arkenbout EK; Carmeliet P; Lindner V; Pannekoek H
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1978-83. PubMed ID: 12482822
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Selman SH; Jankun J
Oncol Rep; 2004 Dec; 12(6):1155-62. PubMed ID: 15547731
[TBL] [Abstract][Full Text] [Related]
18. Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1.
Hjortland GO; Bjørnland K; Pettersen S; Garman-Vik SS; Emilsen E; Nesland JM; Fodstad O; Engebraaten O
Clin Exp Metastasis; 2003; 20(4):301-9. PubMed ID: 12856717
[TBL] [Abstract][Full Text] [Related]
19. Enhanced in vitro proliferation of aortic endothelial cells from plasminogen activator inhibitor-1-deficient mice.
Ploplis VA; Balsara R; Sandoval-Cooper MJ; Yin ZJ; Batten J; Modi N; Gadoua D; Donahue D; Martin JA; Castellino FJ
J Biol Chem; 2004 Feb; 279(7):6143-51. PubMed ID: 14625301
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic cues from vascular basement membrane collagen.
Colorado PC; Torre A; Kamphaus G; Maeshima Y; Hopfer H; Takahashi K; Volk R; Zamborsky ED; Herman S; Sarkar PK; Ericksen MB; Dhanabal M; Simons M; Post M; Kufe DW; Weichselbaum RR; Sukhatme VP; Kalluri R
Cancer Res; 2000 May; 60(9):2520-6. PubMed ID: 10811134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]